CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 37.27% | -21.90% | — | |
| 2 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 26.07% | — | — | |
| 3 | KLDO | Kaleido Biosciences INC | Stock-Other | 8.72% | — | — | |
| 4 | DNLI | Denali Therapeutics INC | Stock-Other | 7.19% | — | — | |
| 5 | ✓ | Evelo Biosciences INC | Stock-Other | 7.09% | — | — | |
| 6 | ✓ | Axcella Health INC Com New | Stock-Other | 3.53% | — | — | |
| 7 | TMDX | Transmedics Group INC | Stock-Healthcare | 3.18% | — | — | |
| 8 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 3.01% | — | +70.09% | |
| 9 | QTRX | Quanterix CORP | Stock-Other | 2.67% | — | -10.10% | |
| 10 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 1.28% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Evelo Biosciences INC | +1.6% | — | Unchanged |
| 2 | QTRX | Quanterix CORP | +0.7% | -10.10% | Trim |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | +0.2% | — | Unchanged |
| 4 | DNLI | Denali Therapeutics INC | +0.2% | — | Unchanged |
| 5 | RUBYUSD | Rubius Therapeutics INC | -0.2% | — | Unchanged |
| 6 | MCRB1EUR | Seres Therapeutics INC | -0.3% | +70.09% | Add |
| 7 | KLDO | Kaleido Biosciences INC | -0.8% | — | Unchanged |
| 8 | MRNA | Moderna INC | -8% | — | Unchanged |
| 9 | ✓ | Axcella Health INC Com New | — | NEW | New buy |
| 10 | TMDX | Transmedics Group INC | — | NEW | New buy |